Oil prices fall as key Russian port resumes loadings, easing supply risks
BFI Co., LLC, a ten percent owner of Phibro Animal Health Corp (NASDAQ:PAHC), sold 29,337 shares of Class A Common Stock between November 12 and November 13, 2025, for approximately $1.36 million. The sales were executed at prices ranging from $44.3689 to $45.2255.
According to a Form 4 filing with the Securities and Exchange Commission, the transactions were executed according to a pre-arranged Rule 10b5-1 trading plan adopted on May 30, 2025.
On November 11, BFI Co., LLC also converted 15,000 shares of Class B Common Stock into Class A Common Stock. The price per share was $0. Following these transactions, BFI Co., LLC indirectly holds 5,240 shares of Class A Common Stock.
Jack Bendheim, President and CEO, as well as a director and ten percent owner of Phibro Animal Health Corp, may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. He directly holds 16,840 shares of Class A Common Stock.
In other recent news, Phibro Animal Health Corporation reported impressive financial results for the first quarter of fiscal year 2026. The company posted earnings per share of $0.73, surpassing the projected $0.60, marking a significant earnings surprise of 21.67%. Additionally, Phibro’s revenue reached $363.9 million, exceeding expectations of $345.44 million. These results indicate strong performance and have contributed to increased investor confidence. Meanwhile, BofA Securities adjusted its price target for Phibro Animal Health to $32.00 from the previous $27.00, while maintaining an Underperform rating. The revised price target reflects improved profitability in the Livestock sector and reduced costs for feed and grain inputs. These developments suggest a strengthening of Phibro’s position in the industry.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.